<div dir="ltr"><div class="gmail_extra"><div class="gmail_quote">On 17 December 2013 22:38, Couture Marc <span dir="ltr"><<a href="mailto:marc.couture@teluq.ca" target="_blank">marc.couture@teluq.ca</a>></span> wrote:<br>
<blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div lang="FR-CA" link="blue" vlink="purple">
<div><div>
<p class="MsoNormal"><span style="font-family:Calibri,sans-serif;font-size:11pt;color:rgb(34,34,34)">I’m in the editorial board of an OA journal which uses -NC but doesn’t ask authors to grant it a license, so the authors keep the exploitation rights.</span><br>
</p></div>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif"">The problem with Elsevier is that they require (even for CC-BY) an exclusive license to publish that effectively makes them the ones who give permissions (and pocket the
money).</span></p></div></div></blockquote><div><br></div><div>To re-iterate a previous discussion, an exclusive publishing license exists between the author and the publisher, and can not limit anyone downstream with what they can do according to the terms of the licence they have been granted. So anything that is CC-BY would allow full derivative and commercial use providing there is appropriate attribution. It's impossible for the exclusive license to limit that.</div>
<div><br></div><div>For rights not covered by the licence (e.g. commercial use for an -NC), and this may be dependent on the license between author / publisher (but it would need to be more specific than exclusive publishing rights of the article), then the copyright holder is able to grant those rights.</div>
<div><br></div><div>G</div>
</div></div></div>